VolitionRx Limited (VNRX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

VolitionRx Limited (VNRX) is down 73.8% since the beginning of the year. At $1 per share, VNRX is trading 92.7% below its 52-week high of $18. Investors who bought $1,000 worth of VNRX shares 5 years ago would now be looking at an investment worth $21.

VolitionRx Limited (VNRX) has returned -73.79% so far this year and -92.72% over the past 12 months. Over the last ten years, VNRX has returned -32.48% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Oct 11, 2011, VNRX's average daily return is +0.03%, while the average monthly return is -0.33%.

Historically, 42% of months were positive and 58% were negative. The best month was Sep 2014 with a return of +109.4%, while the worst month was Jun 2026 at -49.8%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.

On a daily basis, VNRX closed higher 40% of trading days. The best single day was Oct 26, 2011 with a return of +50.0%, while the worst single day was Sep 22, 2023 at -32.1%.

VolitionRx Limited has an annualized alpha of -2.01%, beta of 0.74, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since October 11, 2011.

• This stock participated in 137.95% of S&P 500 Index downside but only -12.82% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

VNRX ranks 3 for risk / return — in the bottom 3% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the VolitionRx Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the VolitionRx Limited was 98.97%, occurring on Jun 22, 2026. The portfolio has not yet recovered.

The current VolitionRx Limited drawdown is 98.97%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of VolitionRx Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how VolitionRx Limited is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.